Assessing Salmonella Typhi Pathogenicity and Prevention: The Crucial Role of Vaccination in Combating Typhoid Fever
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26093981 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Elena Roxana Buzilă und 4 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Discipline, Preventive Medicine and Interdisciplinarity Department, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, …. Hauptthemen laut MEDLINE: Salmonella typhi, Typhoid Fever, Typhoid-Paratyphoid Vaccines. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Enteric fever is caused by Salmonella enterica serovar Typhi (S. Typhi) and Salmonella enterica serovar Paratyphi (S. Paratyphi) A, B, and C. Globally, an estimated 11 to 21 million cases of typhoid and paratyphoid fever occur annually, with approximately 130,000–160,000 deaths, most of which are reported in South/Southeast Asia and sub-Saharan Africa. The antibiotic susceptibility of S. Typhi strains varies between countries within broad limits, from 3% to 97% for ampicillin, 9% to 95% for ciprofloxacin, 4% to 94% for chloramphenicol (India vs. Pakistan), and 0% to 99% for ceftriaxone (India vs. Iraq). With S. Typhi increasingly exhibiting resistance to antibiotics, vaccination becomes an essential preventive measure. Currently, three vaccines are licensed for typhoid fever: the typhoid conjugate vaccine (TCV), live-attenuated oral vaccine Ty21a (Ty21a), and Vi capsular polysaccharide vaccine (Vi-CPS). While no specific vaccine exists for paratyphoid fever, the genetic and antigenic similarities between S. Paratyphi and S. Typhi offer potential for the development of such a vaccine. Early studies show promising results, demonstrating both safety and immunogenicity in preclinical trials. Whole genome sequencing (WGS) provides a powerful tool for assigning genotypes, identifying plasmids, comparing genetic elements, and investigating molecular factors that contribute to antibiotic resistance and virulence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology Discipline, Preventive Medicine and Interdisciplinarity Department, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.
- Iasi Regional Center for Public Health, National Institute of Public Health, 700465 Iasi, Romania.
- Clinical Hospital of Infectious Diseases "Sf. Parascheva", 700116 Iasi, Romania.
- "Sf. Spiridon" Clinical Emergency Hospital, 700111 Iasi, Romania.
ORCID-Profile: Elena Roxana Buzilă, Olivia Simona Dorneanu, Felicia Trofin, Luminița Smaranda Iancu
Zitieren
APA
Buzilă, E. R., Dorneanu, O. S., Trofin, F., Sima, C. M., & Iancu, L. S. (2025). Assessing Salmonella Typhi Pathogenicity and Prevention: The Crucial Role of Vaccination in Combating Typhoid Fever. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26093981
Vancouver
Buzilă ER, Dorneanu OS, Trofin F, Sima CM, Iancu LS. Assessing Salmonella Typhi Pathogenicity and Prevention: The Crucial Role of Vaccination in Combating Typhoid Fever. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26093981
BibTeX
@article{Buzil2025,
author = {Buzilă, Elena Roxana and Dorneanu, Olivia Simona and Trofin, Felicia and Sima, Cristina Mihaela and Iancu, Luminița Smaranda},
title = {Assessing Salmonella Typhi Pathogenicity and Prevention: The Crucial Role of Vaccination in Combating Typhoid Fever},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26093981}
}
EUVIMED